ZYDELIG (idelalisib) Gilead sciences inc Patent: 6,800,620 Expiration: Apr 24, 2021 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of April 18, 2021 Read Post »
ZYDELIG (idelalisib) Gilead sciences inc Patent: 6,800,620 Expiration: Apr 24, 2021 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of April 18, 2021 Read Post »
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It
Annual Drug Patent Expirations for ALTABAX Altabax is a drug marketed by Almirall and is included in one NDA. It
Annual Drug Patent Expirations for ERAXIS Eraxis is a drug marketed by Vicuron and is included in one NDA. It
Annual Drug Patent Expirations for REQUIP+XL Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one
New patent expiration for Glaxosmithkline Llc drug REQUIP XL Read Post »
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Abraxis Bioscience and is included in one NDA.
New patent expiration for Abraxis Bioscience drug ABRAXANE Read Post »
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one
New patent expiration for Optinose Us drug XHANCE Read Post »
Annual Drug Patent Expirations for SEEBRI Seebri is a drug marketed by Novartis and is included in one NDA. It
Get fresh news and insights, drug patent expirations & more…
